Thermo Fisher acquires Henogen viral vector manufacturing business in Belgium from Novasep
Thermo Fisher Scientific has completed the acquisition of Groupe Novasep’s acquisition of viral vector manufacturing business in Belgium – Henogen for nearly €725 million in cash. The divested viral vector manufacturing business of Novasep offers contract manufacturing services for vaccines and therapies to biotech firms and large biopharma customers. Through its two locations in Seneffe […]